295 related articles for article (PubMed ID: 29641429)
1. Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia.
Anderson R; Nel JG; Feldman C
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641429
[TBL] [Abstract][Full Text] [Related]
2. The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy.
Anderson R; Feldman C
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446214
[TBL] [Abstract][Full Text] [Related]
3. Pneumolysin as a potential therapeutic target in severe pneumococcal disease.
Anderson R; Feldman C
J Infect; 2017 Jun; 74(6):527-544. PubMed ID: 28322888
[TBL] [Abstract][Full Text] [Related]
4. Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia.
Feldman C; Anderson R
Front Immunol; 2020; 11():577303. PubMed ID: 33042161
[TBL] [Abstract][Full Text] [Related]
5. Apigenin protects mice from pneumococcal pneumonia by inhibiting the cytolytic activity of pneumolysin.
Song M; Li L; Li M; Cha Y; Deng X; Wang J
Fitoterapia; 2016 Dec; 115():31-36. PubMed ID: 27693741
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A.
Song M; Teng Z; Li M; Niu X; Wang J; Deng X
J Cell Mol Med; 2017 Oct; 21(10):2586-2598. PubMed ID: 28402019
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia.
Feldman C; Normark S; Henriques-Normark B; Anderson R
J Intern Med; 2019 Jun; 285(6):635-652. PubMed ID: 30584680
[TBL] [Abstract][Full Text] [Related]
8. Acacetin inhibits Streptococcus pneumoniae virulence by targeting pneumolysin.
Li S; Lv Q; Sun X; Tang T; Deng X; Yin Y; Li L
J Pharm Pharmacol; 2020 Aug; 72(8):1092-1100. PubMed ID: 32390150
[TBL] [Abstract][Full Text] [Related]
9. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
[TBL] [Abstract][Full Text] [Related]
10. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms.
Shak JR; Ludewick HP; Howery KE; Sakai F; Yi H; Harvey RM; Paton JC; Klugman KP; Vidal JE
mBio; 2013 Sep; 4(5):e00655-13. PubMed ID: 24023386
[TBL] [Abstract][Full Text] [Related]
11. Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation.
Bewley MA; Naughton M; Preston J; Mitchell A; Holmes A; Marriott HM; Read RC; Mitchell TJ; Whyte MK; Dockrell DH
mBio; 2014 Oct; 5(5):e01710-14. PubMed ID: 25293758
[TBL] [Abstract][Full Text] [Related]
12. Verbascoside Alleviates Pneumococcal Pneumonia by Reducing Pneumolysin Oligomers.
Zhao X; Li H; Wang J; Guo Y; Liu B; Deng X; Niu X
Mol Pharmacol; 2016 Mar; 89(3):376-87. PubMed ID: 26700563
[TBL] [Abstract][Full Text] [Related]
13. The biology of pneumolysin.
Mitchell TJ; Dalziel CE
Subcell Biochem; 2014; 80():145-60. PubMed ID: 24798011
[TBL] [Abstract][Full Text] [Related]
14. Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia.
Anderson R; Feldman C
J Infect; 2017 Dec; 75(6):473-485. PubMed ID: 28943342
[TBL] [Abstract][Full Text] [Related]
15. The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia.
Feldman C; Anderson R
Semin Respir Crit Care Med; 2016 Dec; 37(6):806-818. PubMed ID: 27960205
[No Abstract] [Full Text] [Related]
16. Clarithromycin Inhibits Pneumolysin Production via Downregulation of
Domon H; Isono T; Hiyoshi T; Tamura H; Sasagawa K; Maekawa T; Hirayama S; Yanagihara K; Terao Y
Microbiol Spectr; 2021 Oct; 9(2):e0031821. PubMed ID: 34468195
[TBL] [Abstract][Full Text] [Related]
17. Juglone alleviates pneumolysin-induced human alveolar epithelial cell injury via inhibiting the hemolytic activity of pneumolysin.
Song M; Lu G; Li M; Deng X; Wang J
Antonie Van Leeuwenhoek; 2017 Aug; 110(8):1069-1075. PubMed ID: 28451868
[TBL] [Abstract][Full Text] [Related]
18.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
19. Shikonin alleviates the biotoxicity produced by pneumococcal pneumolysin.
Zhao X; Zhou Y; Wang L; Li M; Shi D; Li D; Wang J
Life Sci; 2017 May; 177():1-7. PubMed ID: 28385613
[TBL] [Abstract][Full Text] [Related]
20. Pneumolysin: a multifunctional pneumococcal virulence factor.
Rubins JB; Janoff EN
J Lab Clin Med; 1998 Jan; 131(1):21-7. PubMed ID: 9452123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
